Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: Staging with 18F-FDG PET/CT

Acta Radiologica

Volumn 52, Issue 9, 2011, Pages 970-972

  Makis, William ^a   Ciarallo, Anthony ^b   Lisbona, Robert ^b  

^a Brandon Regional Health Centre   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

FDG; Fluorodeoxyglucose; HIV; Oral cavity lymphoma; PET CT; Plasmablastic lymphoma

Indexed keywords

FDG; FLUORODEOXYGLUCOSE; HIV; ORAL CAVITY LYMPHOMA; PLASMABLASTIC LYMPHOMA;

RADIOLOGY;

ONCOLOGY;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LARGE CELL LYMPHOMA; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

FEMALE; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 83155165175     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110123     Document Type: Article

References (17)

1. Flaitz CM, Nichols CM, Walling DM, et al. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 2002;38:96-102 (Pubitemid 34076578)
2. Porter SR, Diz Dios P, Kumar N, et al. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:730-4
3. Lester R, Li C, Phillips P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004;45:1881-5 (Pubitemid 38997157)
4. Panos G, Karveli EA, Nikolatou O, et al. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 2007;82:761-5 (Pubitemid 47221664)
5. Carbone A, Gaidano G, Gloghini A, et al. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 1999;108:95-9 (Pubitemid 29062127)
6. Raviele PR, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Diseases 2009;15:38-45
7. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005;29:1633-41
8. Cioc AM, Allen C, Kalmar JR, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004;28:41-6 (Pubitemid 38031619)
9. Valera A, Balague O, Colomo L, et al. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 2010;34:1686-94
10. Ouansafi I, He B, Fraser C, et al. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol 2010;134:972-81
11. Villiringer K, Jager H, Dichgans M, et al. Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 1995;19:532-6
12. Heald AE, Hoffman JM, Bartlett JA, et al. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 1996;7:337-46 (Pubitemid 26330308)
13. Warwick JM, Sathekge MM. PET/CT scanning with a high HIV/AIDS prevalence. Transfus Apher Sci 2011;4:167-72
14. Morooka M, Ito K, Kubota K, et al. Usefulness of F-18 FDG PET/CT in a case of Kaposi sarcoma with an unexpected bone lesion. Clin Nucl Med 2011;36:231-4
15. Sathekge M, Maes A, Kgomo M, et al. FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: implications for cancer staging. Q J Nucl Med Mol Imaging 2010;54:698-703
16. Schichman SA, McClure R, Schaefer RF, et al. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 2004;77:291-5 (Pubitemid 39430709)
17. Hausermann P, Khanna N, Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation. Dermatology 2004;208:287-90 (Pubitemid 38594556)